Dr. Koehler joins the Silverback Board of Directors after a successful academic career and more than 20 years of experience in both large, multinational pharmaceutical and biotechnology companies. She is an innovative leader, frequently called upon by academic, venture capital and industry leaders for her creative and strategic approaches to bringing drugs to global markets, in- and out-licensing, and initiating academic or industry partnerships. Her strong clinical, translational, and scientific background, extensive hands-on experience in all stages of drug development, and deep, versatile and successful external contacts make her a credible voice in decision making and finding suitable partnerships within the world of biotechnology. Board certified in hematology/oncology, she has experience in both early drug development. Dr. Koehler currently serves as the Chief Medical Officer at Repare Therapeutics, leading clinical strategy and overseeing all operations. Prior to joining Repare, Dr. Koehler was Chief Medical Officer at Bicycle Therapeutics. Prior to that, she was Vice President of Strategy and Innovation for Pfizer Oncology, where she led the development of palbociclib (IBRANCE) and contributed to the strategic direction of the oncology portfolio. Dr. Koehler received her M.D. and Ph.D. from the Silesian Medical School in Poland and has co-authored over 150 publications, book chapters, and patents.